KRYS - Krystal Biotech announces sale of priority review voucher for $100 million August, 21 2023 07:31 AM Krystal Biotech Inc. 2023-08-21 07:31:33 ET More on Krystal Biotech Krystal Biotech: Pioneering Rare Disease Gene Therapies Seeking Alpha’s Quant Rating on Krystal Biotech Earnings data for Krystal Biotech For further details see: Krystal Biotech announces sale of priority review voucher for $100 million